Mayenne, France

Jean-Pierre Pilleux


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2011

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jean-Pierre Pilleux

Introduction

Jean-Pierre Pilleux, a prominent inventor based in Mayenne, France, is known for his significant contributions to the field of pharmaceuticals. With a portfolio that includes five patents, Pilleux has made strides in the development of novel compounds aimed at addressing critical health issues. His work highlights the importance of innovation in medical research and drug development.

Latest Patents

Among his latest contributions, Pilleux has patented N-aroyl cyclic amine derivatives as orexin receptor antagonists. These derivatives are recognized for their potential pharmaceutical application, particularly in the treatment of conditions related to the orexin receptor. The disclosed compounds have specific structural formulas that outline their potential uses in medical therapies. This work demonstrates not only Pilleux's innovative spirit but also his commitment to advancing healthcare solutions.

Career Highlights

Jean-Pierre Pilleux has dedicated his professional career to research and development within the pharmaceutical sector. He is currently affiliated with SmithKline Beecham Corporation, where he has been instrumental in pioneering new drug formulations. His inventive methodologies and persistent pursuit of knowledge have earned him recognition within the scientific community.

Collaborations

Pilleux has worked alongside notable colleagues such as Clive Leslie Branch and Wai Ngor Chan. These collaborations reflect the collaborative nature of scientific research, where ideas and expertise converge to foster innovation and implement effective solutions in the realm of pharmaceuticals.

Conclusion

In summary, Jean-Pierre Pilleux's contributions to pharmaceutical development through his patents underline his role as a significant inventor in the industry. His work as an orexin receptor antagonist developer illustrates the potential for innovative compounds to transform therapeutic practices, paving the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…